170 related articles for article (PubMed ID: 31622444)
21. Epoxyeicosatrienoic Acids are Mediated by EPHX2 Variants and may be a Predictor of Early Neurological Deterioration in Acute Minor Ischemic Stroke.
Yi X; Lin J; Li J; Zhou Q; Han Z
J Atheroscler Thromb; 2017 Dec; 24(12):1258-1266. PubMed ID: 28835580
[TBL] [Abstract][Full Text] [Related]
22. CYP3A genotypes of donors but not those of the patients increase the risk of acute rejection in renal transplant recipients on calcineurin inhibitors: a pilot study.
Gervasini G; García-Pino G; Vergara E; Mota-Zamorano S; García-Cerrada M; Luna E
Eur J Clin Pharmacol; 2018 Jan; 74(1):53-60. PubMed ID: 29043387
[TBL] [Abstract][Full Text] [Related]
23. Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice.
Zhu Y; Blum M; Hoff U; Wesser T; Fechner M; Westphal C; Gürgen D; Catar RA; Philippe A; Wu K; Bubalo G; Rothe M; Weldon SM; Dragun D; Schunck WH
PLoS One; 2016; 11(1):e0145645. PubMed ID: 26727266
[TBL] [Abstract][Full Text] [Related]
24. In vivo activity of epoxide hydrolase according to sequence variation affects the progression of human IgA nephropathy.
Lee JP; Yang SH; Kim DK; Lee H; Kim B; Cho JY; Yu KS; Paik JH; Kim M; Lim CS; Kim YS
Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1283-90. PubMed ID: 21429967
[TBL] [Abstract][Full Text] [Related]
25. Preservation of epoxyeicosatrienoic acid bioavailability prevents renal allograft dysfunction and cardiovascular alterations in kidney transplant recipients.
Duflot T; Laurent C; Soudey A; Fonrose X; Hamzaoui M; Iacob M; Bertrand D; Favre J; Etienne I; Roche C; Coquerel D; Le Besnerais M; Louhichi S; Tarlet T; Li D; Brunel V; Morisseau C; Richard V; Joannidès R; Stanke-Labesque F; Lamoureux F; Guerrot D; Bellien J
Sci Rep; 2021 Feb; 11(1):3739. PubMed ID: 33580125
[TBL] [Abstract][Full Text] [Related]
26. Intakes of omega-3 polyunsaturated fatty acids and blood pressure change over time: Possible interaction with genes involved in 20-HETE and EETs metabolism.
Tagetti A; Ericson U; Montagnana M; Danese E; Almgren P; Nilsson P; Engström G; Hedblad B; Minuz P; Orho-Melander M; Fava C; Melander O
Prostaglandins Other Lipid Mediat; 2015 Jul; 120():126-33. PubMed ID: 25986600
[TBL] [Abstract][Full Text] [Related]
27. Association of baseline histopathology and kidney donor risk index with graft outcomes in deceased donor kidney transplantation
.
Park KS; Park SJ; Park H; Kim M; Park J; Chung HC; Cho HR; Lee JS
Clin Nephrol; 2019 Jun; 91(6):363-369. PubMed ID: 30848240
[TBL] [Abstract][Full Text] [Related]
28. Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases.
Zordoky BN; El-Kadi AO
Pharmacol Ther; 2010 Mar; 125(3):446-63. PubMed ID: 20093140
[TBL] [Abstract][Full Text] [Related]
29. Kidneys From Deceased Elderly Donors: Factors Associated With Adverse Outcomes.
Adekoya AO; Halawa A
Exp Clin Transplant; 2016 Feb; 14(1):32-7. PubMed ID: 26862822
[TBL] [Abstract][Full Text] [Related]
30. Genetic interactions between the donor and the recipient for susceptibility to acute rejection in kidney transplantation: polymorphisms of CCR5.
Cha RH; Yang SH; Kim HS; Kim SM; Park MH; Ha J; Kim YS
Nephrol Dial Transplant; 2009 Sep; 24(9):2919-25. PubMed ID: 19561149
[TBL] [Abstract][Full Text] [Related]
31. Outcome of kidney transplantation from high-risk donors is determined by both structure and function.
Karpinski J; Lajoie G; Cattran D; Fenton S; Zaltzman J; Cardella C; Cole E
Transplantation; 1999 Apr; 67(8):1162-7. PubMed ID: 10232568
[TBL] [Abstract][Full Text] [Related]
32. Small kidneys for large recipients: does size matter in renal transplantation?
Dinis P; Nunes P; Marconi L; Furriel F; Parada B; Moreira P; Figueiredo A; Bastos C; Roseiro A; Dias V; Rolo F; Alves R; Mota A
Transplant Proc; 2015 May; 47(4):920-5. PubMed ID: 26036486
[TBL] [Abstract][Full Text] [Related]
33. The impact of kidney donor profile index on delayed graft function and transplant outcomes: A single-center analysis.
Zens TJ; Danobeitia JS; Leverson G; Chlebeck PJ; Zitur LJ; Redfield RR; D'Alessandro AM; Odorico S; Kaufman DB; Fernandez LA
Clin Transplant; 2018 Mar; 32(3):e13190. PubMed ID: 29314286
[TBL] [Abstract][Full Text] [Related]
34. Predictors of renal transplant histology at three months.
Kuypers DR; Chapman JR; O'Connell PJ; Allen RD; Nankivell BJ
Transplantation; 1999 May; 67(9):1222-30. PubMed ID: 10342313
[TBL] [Abstract][Full Text] [Related]
35. A single-center cohort study to define the role of pretransplant biopsy score in the long-term outcome of kidney transplantation.
Losappio V; Stallone G; Infante B; Schena A; Rossini M; Maiorano A; Fiorentino M; Ditonno P; Lucarelli G; Battaglia M; Gesualdo L; Grandaliano G
Transplantation; 2014 May; 97(9):934-9. PubMed ID: 24342976
[TBL] [Abstract][Full Text] [Related]
36. Expanding the criteria of renal kidneys for transplantation: use of donors with acute renal failure.
Deroure B; Kamar N; Depreneuf H; Jacquet A; Francois H; Charpentier B; Rostaing L; Durrbach A
Nephrol Dial Transplant; 2010 Jun; 25(6):1980-6. PubMed ID: 20167568
[TBL] [Abstract][Full Text] [Related]
37. Joint Assessment of Donor and Recipient hTERT Gene Polymorphism Provides Additional Information for Early Kidney Transplantation Outcomes.
Kłoda K; Mierzecki A; Domański L; Borowiecka E; Safranow K; Ciechanowicz A; Ciechanowski K
Med Sci Monit; 2017 Apr; 23():1812-1818. PubMed ID: 28410362
[TBL] [Abstract][Full Text] [Related]
38. Transplantation with kidneys retrieved from deceased donors with acute renal failure.
Klein R; Galante NZ; de Sandes-Freitas TV; de Franco MF; Tedesco-Silva H; Medina-Pestana JO
Transplantation; 2013 Feb; 95(4):611-6. PubMed ID: 23274968
[TBL] [Abstract][Full Text] [Related]
39. Homozygosity for the EPHX2 K55R polymorphism increases the long-term risk of ischemic stroke in men: a study in Swedes.
Fava C; Montagnana M; Danese E; Almgren P; Hedblad B; Engström G; Berglund G; Minuz P; Melander O
Pharmacogenet Genomics; 2010 Feb; 20(2):94-103. PubMed ID: 20065888
[TBL] [Abstract][Full Text] [Related]
40. CYP2C8*3 polymorphism and donor age are associated with allograft dysfunction in kidney transplant recipients treated with calcineurin inhibitors.
Gervasini G; Garcia M; Macias RM; Benitez J; Caravaca F; Cubero JJ
J Clin Pharmacol; 2013 Apr; 53(4):427-34. PubMed ID: 23426640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
